Physician profile
Robert Segal
NPI 1265408264
$40,903.26
in general payments reported to CMS, 2019-2025
31 companies · $5,483 in 2025
The $5,483 reported for 2025 was more than what 90% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $8,199 · 2021: $3,456 · 2022: $2,753 · 2023: $1,442 · 2024: $1,674 · 2025: $5,483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,650 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,870 · Travel and Lodging: $65.80 · Education: $12.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,649.98 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,870.00 |
| Travel and Lodging | $65.80 |
| Education | $12.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $16,902.83 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $8,514.54 | 2019-2025 | Pifeltro, Dificid, Delstrigo |
| Shionogi INC | $4,410.32 | 2024-2025 | Fetroja |
| Abbvie INC. | $4,283.28 | 2021-2025 | Dalvance, Avycaz, Teflaro |
| Gilead Sciences, INC. | $1,889.26 | 2019-2025 | Biktarvy |
| Organogenesis INC. | $1,304.36 | 2021-2025 | Apligraf, Affinity, Apligraf |
| Viiv Healthcare Company | $980.44 | 2019-2025 | Dovato, Apretude, Cabenuva |
| Smith+Nephew, INC. | $345.87 | 2019-2025 | Collagenase Santyl, "Acticoat 4"" X 4""", Grafix Pl |
| Insmed, INC. | $340.45 | 2019-2025 | Arikayce |
| Paratek Pharmaceuticals, INC. | $290.86 | 2019-2025 | Nuzyra |
| Aimmune Therapeutics, INC. | $194.63 | 2023-2025 | Zenpep, Vowst |
| Urgo Medical North America, LLC | $170.38 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2 |
| La Jolla Pharmaceutical Company | $152.50 | 2020-2022 | |
| Janssen Biotech, INC. | $145.87 | 2019-2023 | Symtuza |
| Aroa Biosurgery Incorporated | $132.19 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $131.37 | 2019 | |
| Csl Behring | $123.45 | 2021 | |
| Theratechnologies INC. | $116.71 | 2023-2025 | Trogarzo, Egrifta |
| Melinta Therapeutics, LLC | $115.07 | 2019-2023 | Orbactiv, Kimyrsa, Vabomere |
| Kerecis Limited | $73.73 | 2020-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $71.76 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Novartis Pharmaceuticals Corporation | $37.41 | 2024 | |
| Ferring Pharmaceuticals INC. | $31.03 | 2023 | Rebyota |
| Janssen Products, Lp | $28.99 | 2019 | |
| Kci USA, INC. | $20.20 | 2022 | |
| Tactile Systems Technology INC | $19.50 | 2023 | Entre Plus, Flexitouch Plus |
| Reprise Biomedical, INC. | $18.35 | 2023 | Miroderm, Miro3d, Miro3d Fibers |
| Bioventus LLC | $15.85 | 2022 | |
| Emd Serono, INC. | $15.00 | 2019 | |
| Shire North American Group INC | $13.58 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Segal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.